Evaluating the effects of perflurohexyloctane on biometry: A Q&A with Kayla Karpuk, OD, from ARVO 2025

Published on May 16, 2025
Can a drop of perfluorohexyloctane, known to persist in the tear film, influence the precision of keratometry and ultimately affect surgical planning?
Continue reading on website
Other news

Dipeptidyl Peptidase-4 Inhibitors Lower POAG, NTG Risk in Diabetes Patients

May 16, 2025
In previous studies, DPP4i have demonstrated potential neuroprotective effects independent of glycemic control, which may have contributed to the reduced risk of glaucoma observed in this study. This chart from the study shows a significantly lower cumulative incidence of POAG in DPP4i vs. non-DPP4i users. Photo: Lu Y-A, et al. Ophthalmol Sci. May 8, 2025. Click image to enlarge.

Nicox releases results from Whistler phase 3b trial in IOP lowering eye drops

May 16, 2025
NCX 470, Nicox’s lead clinical product candidate, is a novel NO-donating bimatoprost eye drop with a dual mechanism of action (nitric oxide and prostaglandin analog).